About
Menssana Research is the leading developer of advanced new breath tests for detection of disease. We are now performing clinical studies with the BCA and with BreathLink (TM), mostly funded by the National Institutes of Health and BARDA, to evaluate breath testing in several diseases including lung cancer, breast cancer, heart transplant rejection, radiation exposure, and tuberculosis. The Food and Drug Administration has approved the Heartsbreath test for heart transplant rejection for clinical use. For more information, please visit menssanaresearch.com.
Technologies
Outlook
GoDaddy Hosting
YouTube
Mobile Friendly
Apache
Google Font API
WordPress.org
Remote
AI
Keywords
pointofcare breath testing & analysis
labbased analysis available for cliniciansclients
personal tests available for breath testing & analysis
medical equipment manufacturing
breath test for breast cancer
disease biomarkers
biomarkers in breath
biotechnology
breath analysis
medical equipment
non-invasive diagnostics
breath biomarkers of influenza
cancer screening
b2c
healthcare
services
breath testing
breath biomarkers of radiation
cost-effective testing
diagnostic technology
d2c
rapid screening
medical and diagnostic laboratories
early disease detection
gas chromatography
volatile biomarkers
medical diagnostics
biomarkers of pulmonary tuberculosis
disease detection
biomarker analysis
Company Information
-
Employees 5
Location
211 Warren St, Newark, New Jersey, United States, 07103
